BioCentury
ARTICLE | Company News

Astex Pharmaceuticals, J&J deal

June 18, 2012 7:00 AM UTC

Astex received a £3.5 million ($5.4 million) milestone payment from Johnson & Johnson under a 2008 deal granting the pharma exclusive, worldwide rights to develop and market compounds arising from Ast...